| Literature DB >> 35445853 |
Pavlina Lenga1, Martin Jakobs2, Jessica Jesser3, Philip Dao Trong2, Andreas W Unterberg2, Christopher Beynon2.
Abstract
BACKGROUND: Pituitary tumors may cause compression of the optic chiasm, resulting in decreased visual acuity. Therefore, decompression of the optic chiasm is a major goal of surgical treatment in such patients. Quantitative pupillometry has been used in various clinical settings for assessing the optic system but has not been applied in patients with pituitary tumors. This study aimed to evaluate the potential of this technique to improve treatment modalities in patients undergoing surgical resection of pituitary tumors.Entities:
Keywords: Neurological pupil index; Optic chiasm; Pituitary tumor; Pupillometry
Mesh:
Year: 2022 PMID: 35445853 PMCID: PMC9160135 DOI: 10.1007/s00701-022-05214-w
Source DB: PubMed Journal: Acta Neurochir (Wien) ISSN: 0001-6268 Impact factor: 2.816
Overview of preoperative and postoperative patient characteristics
| Patient (gender, age) | Clinical symptoms | MRI findings (size: height × width × depth) | Surgery | Histopathology | NPi preoperative | NPi postoperative | Clinical outcome | ||
|---|---|---|---|---|---|---|---|---|---|
| Left | Right | Left | Right | ||||||
Female 39 | Visual impairment | Solid tumor 23 × 27 × 15 mm | Near total resection (ioMRI confirmed) | Pituitary adenoma | 3.3 | 3.5 | 3.8 (+ 15%) | 3.7 (+ 6%) | In hospital: uneventful course, improvement of VA FU (33 months): small recurrence (7 mm), normal VA |
Female 63 | Visual impairment | Solid tumor 16 × 20 × 14 mm | Gross total resection (ioMRI confirmed) | Pituitary adenoma | 3.5 | 3.2 | 4.4 (+ 26%) | 4.0 (+ 25%) | In hospital: uneventful course, improvement of VA FU (40 months): no recurrence, normal VA |
Male 56 | Visual impairment Bitemporal hemianopsia | Cystic-solid tumor 31 × 24 × 22 mm | Gross total resection (ioMRI confirmed) | Pituitary adenoma | 3.5 | 4.1 | 4.4 (+ 26%) | 4.5 (+ 10%) | In hospital: uneventful course, improvement of VA FU (4 months): stable, normal VA, Bitemporal hemianopsia (improved) |
Female 17 | Visual impairment Headache | Solid tumor 21 × 21 19 mm | Near total resection (ioMRI confirmed) | Pituitary adenoma (Prolactinoma) | 3.0 | 3.2 | 3.8 (+ 26%) | 4.0 (+ 25%) | In hospital: uneventful course, improvement of VA FU (38 months): stable tumor remnant, normal VA, Cabergoline therapy |
Female 61 | Visual impairment | Solid tumor 10 × 15 × 11 mm | Gross resection (ioMRI confirmed) | Pituitary adenoma (GH-secreting) | 3.8 | 4.4 | 3.9 (+ 3%) | 4.1 (− 7%) | In hospital: uneventful course, improvement of VA FU (29 months): no recurrence, normal VA |
Female 56 | Visual impairment, headaches, double vision | Solid tumor 55 × 31 × 30 mm | Partial resection | Aggressive pituitary adenoma | 3.2 | 3.7 | 4.8 (+ 50%) | 4.8 (+ 30%) | In hospital: uneventful course, improvement of VA Radiation therapy FU (39 months): stable tumor remnant; normal VA |
Female 66 | Visual impairment, double vision Headache | Cystic tumor 27 × 23 × 21 mm | Gross resection (ioMRI confirmed) | Pituitary adenoma | 3.5 | 4.3 | 4.6 (+ 31%) | 4.6 (+ 7%) | In hospital: uneventful course, improvement of VA FU (3 months): normal VA |
ioMRI, intraoperative magnetic resonance imaging; NPI, neurological pupil index; GH, growth hormone
Fig. 1Exemplary results of patients with compression of the optic chiasm. Patient A experienced impaired vision due to a solid pituitary adenoma with compression of the optic chiasm on magnetic resonance imaging (MRI) studies (left). The neurological pupil index (NPi) values were < 4.0 (R, right; L, left) in both pupils and improved considerably after surgical tumor resection (right). Intraoperative MRI demonstrated sufficient decompression of the optic chiasm. Patient B presented with a cystic pituitary adenoma with compression of the optic chiasm (left). Corresponding to the improved visual acuity after surgery, the NPi values improved, and intraoperative MRI demonstrated sufficient decompression of the optic chiasm (right)
Histological features of the pituitary tumors
| Patient | Histopathology | Immunohistochemistry | ||||
|---|---|---|---|---|---|---|
| GFAP | AE 1/3 | EMA | Synaptophysin | Secreted pituitary hormone | ||
Female 39 | Pituitary adenoma | Positive | Positive | Negative | Positive | Prolactin (+ + + +) |
Female 63 | Pituitary adenoma | Negative | Positive | Negative | Positive | Prolactin (+ +) ACTH ( +) |
Male 56 | Pituitary adenoma | Negative | Positive | Negative | Positive | HGH (+ +) ACTH ( +) Prolactin ( +) |
Female 17 | Pituitary adenoma | Negative | Positive | Negative | Positive | Prolactin (+ + + +) HGH (+ +) |
Female 61 | Pituitary adenoma (GH-secreting) | Negative | Positive | Negative | Positive | HGH (+ + +) Prolactin (+ +) |
Female 56 | Aggressive pituitary adenoma* | Negative | Positive | Negative | Positive | Prolactin (+ + + +) |
Female 66 | Pituitary adenoma | Negative | Positive | Negative | Positive | HCG (+ +) Prolactin ( +) LH ( +) |
+ : sparse cells positive
+ + : small cell groups positive
+ + + : larger cell groups positive
+ + + + : ≥ 50% of cells positive
*Ki-Index up to 40% positive, p53 5% of the cell lines positive indicative for the growth of an aggressive pituitary adenoma